A New Marker in Acute Ischemic Stroke Patients: Monocyte/HDL Ratio


Creative Commons License

ALAGÖZ A. N. , Acar B. A. , Gungen B. D. , ARAS Y. G. , Acar T.

KONURALP TIP DERGISI, vol.12, no.1, pp.118-123, 2020 (Journal Indexed in ESCI) identifier

  • Publication Type: Article / Article
  • Volume: 12 Issue: 1
  • Publication Date: 2020
  • Doi Number: 10.18521/ktd.632555
  • Title of Journal : KONURALP TIP DERGISI
  • Page Numbers: pp.118-123

Abstract

Objective: Stroke is a major cause of global morbidity and mortality. Ischemic stroke is usually marked by cell death associated with inflammation and oxidative stress, and the role of inflammation in neurological diseases has become increasingly obvious. In our study, we studied the monocyte / HDL ratio (MHR) which can support the theory of inflammation in stroke and can be used in clinical practice. MHR can be used a prognostic marker in stroke patients base on this theory.